Literature DB >> 22785079

Inhibitors of endocannabinoid breakdown for pain: not so FA(AH)cile, after all.

Vincenzo Di Marzo1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22785079     DOI: 10.1016/j.pain.2012.06.016

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


× No keyword cloud information.
  7 in total

1.  Inhibition of FAAH, TRPV1, and COX2 by NSAID-serotonin conjugates.

Authors:  Tyler M Rose; Christopher A Reilly; Cassandra E Deering-Rice; Clinton Brewster; Chelsea Brewster
Journal:  Bioorg Med Chem Lett       Date:  2014-10-28       Impact factor: 2.823

Review 2.  Modulating the endocannabinoid system in human health and disease--successes and failures.

Authors:  Pál Pacher; George Kunos
Journal:  FEBS J       Date:  2013-04-22       Impact factor: 5.542

Review 3.  Druggable Targets in Endocannabinoid Signaling.

Authors:  Ann M Gregus; Matthew W Buczynski
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

4.  Aryl N-[ω-(6-Fluoroindol-1-yl)alkyl]carbamates as Inhibitors of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and Butyrylcholinesterase: Structure-Activity Relationships and Hydrolytic Stability.

Authors:  Stefan Rudolph; Helmut Dahlhaus; Walburga Hanekamp; Christian Albers; Maximilian Barth; Giulia Michels; Denise Friedrich; Matthias Lehr
Journal:  ACS Omega       Date:  2021-05-14

5.  Safety, Tolerability and Pharmacokinetics of FAAH Inhibitor V158866: A Double-Blind, Randomised, Placebo-Controlled Phase I Study in Healthy Volunteers.

Authors:  Stephen Pawsey; Mike Wood; Helen Browne; Kirsteen Donaldson; Mark Christie; Steven Warrington
Journal:  Drugs R D       Date:  2016-06

Review 6.  Dual-Acting Compounds Targeting Endocannabinoid and Endovanilloid Systems-A Novel Treatment Option for Chronic Pain Management.

Authors:  Natalia Malek; Katarzyna Starowicz
Journal:  Front Pharmacol       Date:  2016-08-17       Impact factor: 5.810

7.  Targeting the endogenous cannabinoid system to treat neuropathic pain.

Authors:  Benjamin K Lau; Christopher W Vaughan
Journal:  Front Pharmacol       Date:  2014-03-03       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.